CORDIS · 228827 · FP7
NANOFOL Folate-based nanobiodevices for integrated diagnosis/therapy targeting chronic inflammatory diseases
Coordinator: UNIVERSIDADE DO MINHO (PT)
NANOFOL proposes to develop a new diagnostic/therapy approach using folate based nanobiodevices (FBN) able to provide a new type of cost efficient treatment for chronic inflammatory diseases such as Atherosclerosis and Rheumatoid Arthritis with low side effects that will constitute a more advantageous solution than current therapies. NANOFOL will achieve all that by fulfilling the following objectives: •Design , development and production of nanobiodevices (FBN) targeting directly effector cells •Proof of concept in vitro and in vivo of a folate based nanodevice targeting activated macrophage…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
EU contribution: €5.1M awarded to the consortium. The project runs over approximately 4 years from 2009-12-01 to 2013-11-30.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from PT
see all →- Smart4Health — Citizen-centred EU-EHR exchange for personalised health826117 · H2020 · €21.8M
- GIMM-CARE — GIMM-CARE: BOOSTING CLINICAL RESEARCH FOR THE BENEFIT OF SOCIETY101060102 · HORIZON · €15.0M
- MIA-Portugal — Multidisciplinary Institute of Ageing - Portugal857524 · H2020 · €15.0M
- INESCTEC.OCEAN — Centre of Excellence in Ocean Research and Engineering101136903 · HORIZON · €15.0M
- NIMSB — NOVA Institute for Medical Systems Biology101060346 · HORIZON · €15.0M
- BIOPOLIS — Teaming to Upgrade to Excellence in Environmental Biology, Ecosystem Research and AgroBiodiversity857251 · H2020 · €15.0M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the CP-IP funding scheme.
- What is the EU contribution?
- The European Commission contributes €5.1M.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by UNIVERSIDADE DO MINHO (PT).
- What is the project timeline?
- The project runs from 2009-12-01 to 2013-11-30 — approximately 4 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 228827.